The Subdural Hematoma Outcomes in a Population (SD HOP) Study

硬膜下血肿人群 (SD HOP) 研究结果

基本信息

  • 批准号:
    10591861
  • 负责人:
  • 金额:
    $ 20.95万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-03-01 至 2028-02-29
  • 项目状态:
    未结题

项目摘要

Project Summary/Abstract In the United States, subdural hematomas (SDHs) are projected to become the most common cranial neurosurgical condition by 2030. This has major public health implications, as nearly 50% of SDH patients are dead or severely disabled at three months. Despite its importance, there is very little study of this disease at the population-level, particularly with regard to outcomes after patients leave the hospital. Nearly 1 in 6 patients that survive an initial SDH hospitalization are rehospitalized within 90 days, and this risk may be impacted heavily by social determinants of health (SocDH). Regardless, there is no predictive model available to identify SDH survivors at high risk of rehospitalization. Further, SDHs are tightly associated with premorbid antithrombotic use, and these medications are commonly held at the time of presentation, but there is little evidence about the risks and benefits of antithrombotic resumption in SDH survivors. To address these limitations, we will conduct the first population-level study of SDH outcomes in the United States. We will accomplish this relatively quickly and at low cost by utilizing the well-validated infrastructure of the Greater Cincinnati/Northern Kentucky Stroke Study, which has been studying population-level outcomes in stroke and intracranial hemorrhage for more than 30 years. This infrastructure will allow us to determine the 3-year risk of major ischemic and hemorrhagic events after an SDH and determine the predictors for each outcome. We will also a build a predictive model of 90-day rehospitalization or death among SDH patients that utilizes both clinical and SocDH variables. We will use conventional predictive modeling along with modern machine learning techniques, allowing us to maximize predictive ability and potentially identify new variables and interactions that lead to adverse outcomes in SDH survivors. Through this proposal, Dr. Robinson will become an expert in the epidemiology of SDH and in the use of novel data science techniques to analyze large clinical databases. These skills will prepare him to become the next PI of the overall Greater Cincinnati/Northern Kentucky Stroke Study. Dr. Robinson will conduct this work under the guidance of a distinguished mentorship committee: Dr. Brett Kissela, a stroke epidemiologist with expertise in using big data techniques; Dr. Dan Woo, a clinician scientist that studies disparities in intracerebral hemorrhage; Opeolu Adeoye, a neurointensivist and researcher with expertise in acute care research; and Hooman Kamel, a stroke epidemiologist and neurointensivist with expertise in the population-level study of SDHs.
项目总结/文摘

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David Robinson其他文献

David Robinson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David Robinson', 18)}}的其他基金

Molecular Mechanisms Of Synaptic Transmission
突触传递的分子机制
  • 批准号:
    8349615
  • 财政年份:
  • 资助金额:
    $ 20.95万
  • 项目类别:
Molecular Mechanisms Of Synaptic Transmission
突触传递的分子机制
  • 批准号:
    8177715
  • 财政年份:
  • 资助金额:
    $ 20.95万
  • 项目类别:
Molecular Mechanisms Of Synaptic Transmission
突触传递的分子机制
  • 批准号:
    8565491
  • 财政年份:
  • 资助金额:
    $ 20.95万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 20.95万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.95万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 20.95万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.95万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 20.95万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 20.95万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.95万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 20.95万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 20.95万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.95万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了